Puja Ayare

Puja Ayare has extensive work experience in the field of clinical operations and research. Puja currently holds the position of Director, Clinical Operations at Stemline Therapeutics, a role they began in August 2022. Prior to this, Puja worked at Nektar Therapeutics as Director, Clinical Operations from December 2021 to June 2022. At Nektar Therapeutics, they also served as Associate Director, Clinical Operations from January 2020 to December 2021, and as Sr. Clinical Trial Manager from January 2019 to December 2019.

Before joining Nektar Therapeutics, Puja worked at Prothena Corporation plc as a Clinical Trial Manager from February 2016 to December 2018. Prior to that, they gained experience at Onyx Pharmaceuticals, where they served as a Senior Clinical Research Associate from February 2014 to December 2015, and as a Clinical Research Associate II from January 2013 to February 2014. Puja also worked at JANSSEN Alzheimer Immunotherapy as a Senior Clinical Trial Specialist from August 2011 to December 2012.

Puja'scareer in the clinical research field began at ProTrials Research, where Puja served as a Clinical Research Associate from 2006 to 2011.

Puja Ayare holds a Bachelor of Science degree in Biotechnology from the University of California, Davis. The specific start and end years of their education are not provided.